May 2026
Zepbound is ideal for patients who: Want a more aggressive weight-loss option Struggle with metabolic resistance Have tried other treatments but hit plateaus How Wegovy and Zepbound Compare Similarities Both medications: Are FDA-approved for chronic weight management Are given once weekly Improve metabolic function and insulin sensitivity Reduce appetite and cravings Are appropriate for patients with a BMI over 30, or over 27 with weight-related conditions Both are also considered safe when monitored by a qualified medical provider, which is essential to avoid improper dosing and prevent side effects
Members receive personalized lessons, mindset tools, and coaching designed to help them understand how medication, habits, and psychology work together to create lasting results
5,6 JM was scheduled for a phone follow-up in 1 week JM was provided with a demonstration of appropriate injection technique and use of the semaglutide injection device
Primers for RT-PCR are shown in the Supplementary Table 3
A FAERS-based pharmacovigilance analysis comparing tirzepatide vs semaglutide in female reports (Q1 2022Q3 2025) reported gynaecological haemorrhagic events in 0.62% of semaglutide cases (204 cases among 32,839 female-specific reports in that analysis) and did not detect a disproportionate signal vs tirzepatide